This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Barclays, Goldman Sachs, JP Morgan and Morgan Stanley issued bullish rating on Omada Health stock saying the virtual‑care provider could capture more of the large market for diabetes, hypertension and ...

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

The U.S. Supreme Court declined to review a 2023 ruling by the 10th U.S. Circuit Court of Appeals striking down provisions of an Oklahoma law regulating pharmacy benefit managers, The Journal Record ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

The Federal Trade Commission (FTC), charged with protecting the American consumer, on January 15, 2025, issued a special ...

The U.S. Supreme Court declined to review Oklahoma’s PBM law, leaving in place a ruling that found key parts preempted by ERISA and Medicare Part D.

AG Liz Murrill explains why Louisiana filed three major lawsuits against CVS over controversial text messages and business ...